SLRX stock Salarius Pharmaceuticals NASDAQ 18 Mar 2026: Earnings 19 Mar
SLRX stock jumped 29.23% intraday to $0.84 as traders position ahead of Salarius Pharmaceuticals’ earnings call on 19 Mar 2026. This intraday move follows heavy trading volume of 5,962,438 shares versus a 50-day average of 3,681,706. We review catalysts, valuation, technicals, and the near-term earnings risk for investors watching this NASDAQ-listed US biotech.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
